{
  "id": 6279668,
  "title": "Pharmabranche: Erneuter Rückschlag für Novartis – Aktie gibt nach",
  "url": "https://urgent.news/2026/09/08/pharmabranche-erneuter-ruckschlag-fur-novartis-aktie-gibt-nach",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T12:48:05.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/novartis-erneuter-rueckschlag-in-der-entwicklung-aktie-verliert-zweistellig/100252813.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "Erst vor wenigen Tagen hatte das Pharmaunternehmen Novartis Probleme in der Entwicklung eines wichtigen Medikaments gemeldet. Jetzt folgt der nächste Rückschlag. Die Aktie reagiert deutlich.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "NZZ Wirtschaft",
        "title": "Setback for Novartis in preventing heart disease - but hope in another area",
        "url": "https://urgent.news/2026/09/07/ruckschlag-fur-novartis-bei-der-pravention-von-herzerkrankungen-doch",
        "published": "2026-09-07T15:13:59.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}